KatherineFuhMDPhD

PubMed

• APOBEC3A drives ovarian cancer metastasis by altering epithelial-mesenchymal transition.
  Jessica M Devenport, Thi Tran, Brooke R Harris, Dylan Fingerman, Rachel A DeWeerd
  JCI Insight. 2025-03-10
• Delay to timely treatment in locally advanced cervical cancer: insurance inequities in access to gynecologic oncology.
  Jessica Liang, Audrey Mvemba, Megan Swanson, I-Chow Joe Hsu, Edwin Alvarez
  American Journal of Obstetrics and Gynecology. 2025-02-20
• 10 citations
  Tumour evolution and microenvironment interactions in 2D and 3D space.
  Chia-Kuei Mo, Jingxian Liu, Siqi Chen, Erik Storrs, Andre Luiz N Targino da Costa
  Nature. 2024-10-01

Journal Articles

• Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer  
  Ian S Hagemann, Premal H Thaker, Carolyn K McCourt, Katherine C Fuh, David G Mutch, Andrea R Hagemann, Matthew A Powell, Clinical Cancer Research
• Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer  
  Ian S Hagemann, Carolyn K McCourt, Matthew A Powell, Premal H Thaker, David G Mutch, Katherine C Fuh, Andrea R Hagemann, Clinical Cancer Research

Lectures

• Identifying a potential biomarker for anti-PD-1 immunotherapy in patients with advanced stage, surgically-resectable endometrial cancer. 
  2019 ASCO Annual Meeting - 6/1/2019